We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx Sues GlaxoSmithKline Over Wellbutrin XL Patent
Andrx Sues GlaxoSmithKline Over Wellbutrin XL Patent
December 21, 2005
Andrx has filed suit against GlaxoSmithKline (GSK) in a federal court on grounds that GSK’s Wellbutrin XL infringes on an Andrx patent for a once-daily formulation of the active ingredient in the drug.